The combinatorial expression of epithelial and mesenchymal markers in elevated GRHL2 ER-positive cells demonstrates the capacity for ER-positive cells to gain the plasticity needed to overcome the non-native environments that breast cancer cells encounter during the metastatic cascade, while also strengthening the epithelial phenotype. The gene discussed is GRHL2; the disease is breast cancer.